ZOETIS EXECUTIVE TEAM
Executive Vice President and President, Research and Development
Dr. Cathy Knupp was appointed executive vice president and president of Research and Development at Zoetis in November 2012. In this role, she is responsible for leading a global organization that discovers, develops, and registers new products, including genetic predictions, medicines, and vaccines, that help predict, prevent, detect and treat animal health conditions in the eight core species that Zoetis serves. In addition, she leads teams that develop new diagnostic, sensor, and biodevice instruments to complement the core portfolio.
Prior to joining Zoetis, Dr. Knupp served as vice president, Veterinary Medicine Research and Development at Pfizer Animal Health, a position she held since 2005. She also led Pfizer's Michigan laboratories in pharmacokinetics, dynamics and metabolism, and chaired the Midwest Exploratory Development Management Team in Pfizer Global Research and Development.
She began her career in 1987 at Bristol-Myers Squibb where she held positions of increasing responsibility in drug metabolism and pharmacokinetics. This experience led to her appointment as executive director, Drug Metabolism and Pharmacokinetics. Her last position with that company was as vice president, Chemical Manufacturing Controls (CMC), where she was responsible for global CMC regulatory submissions.
As a recipient of the first-ever Feather in Her Cap Award in 2018, Dr, Knupp has been recognized for her leadership and contributions to the animal health industry, and her work in mentoring women and helping them advance their careers in animal health.
Dr. Knupp earned her Doctor of Veterinary Medicine (DVM) degree in 1985 from the University of Illinois, where she also received a master's degree in Toxicology and a bachelor's degree in Veterinary Biosciences. She earned an additional bachelor's degree in Chemistry from Western Illinois University.